Skip to content
GLP-1 Savers

Research & guides

Compounded Tirzepatide Cost: What You Actually Pay per Month

Compare compounded tirzepatide offers, ongoing monthly rates, dose increases and plan commitments. Advertised prices are not always comparable monthly bills.

By Grant Ashford, Founder & Pricing Editor
What's in this guide

The advertised price of compounded tirzepatide can be a starting dose, a prepaid monthly equivalent or an initial-course total. Across the 355 programs we track that publish a tirzepatide price (counted November 2026), the median is about $240 and the lower quartile is around $179. These are advertised figures with mixed supply lengths and conditions, not comparable recurring monthly bills. The cheapest publishing a genuinely flat, month-to-month rate with no plan term is $129. Most advertised figures are starting prices: 229 of the 355 begin with the word "From."

That last number matters more than the median. A "from" price is usually the starting dose or the longest prepay plan. Your real monthly cost depends on the dose you end up on and how long you commit. This page explains how to read the price. Our cheapest tirzepatide ranking lists every program by price.

Compounded tirzepatide prices at a glance

Each program is counted once using the first advertised dollar figure in its tirzepatide listing. This snapshot includes monthly rates, prepaid monthly equivalents, starting offers and initial-course totals; the bands are not a distribution of comparable monthly bills. The flat flag is a program-level classification, not proof that each molecule price is an unconditional monthly rate. Read the actual price and terms in each review.

Advertised figure (mixed offer units)ProgramsProgram flagged flat
$149 or less618
$150 to $199848
$200 to $2495413
$250 to $2996811
$300 to $399706
$400 or more181
All programs35547

Two things stand out:

  • 47 of 355 programs (about 13%) are flagged flat at the program level. Only 16 tirzepatide listings state an unqualified monthly rate. A flat flag alone does not remove a commitment or other condition printed beside the price.
  • The cheapest prices are mostly conditional. Of the 49 programs listing $149 or less, 5 are flagged flat. The lowest figures, starting at $69, come with a required membership fee, a starting-dose-only price, a first-month price or a multi-month plan.

The cheapest flat prices we found

These programs publish a flat month-to-month tirzepatide price, counted October 2026. Read each review for the conditions before you pay. CoreAge Rx now advertises tirzepatide from $129 per month, but conflicting checkout and refund terms mean we keep it out of this unqualified-price table; see the CoreAge Rx review.

ProgramPublished tirzepatide priceWhat the seller says about it
Eden$129/moOne monthly price with no membership fee and no dose-based increase. Its fine print excludes new-member discounts and some plans from that promise
BiltRx$129/mo (compounded)Labels each product FDA approved or not FDA approved next to the price

A low headline often has a condition behind it: Fridays advertises a lowest tirzepatide rate that needs a prepaid year and a promo code, while SnagRx publishes one month-to-month tirzepatide price at every dose and a lower one for a prepaid year. For another price to verify, our Vitara RX review explains why its advertised tirzepatide starting figure needs confirmation against a conflicting program headline.

A program-level flat flag does not guarantee the cheapest bill or remove conditions attached to its offer. A $129 flat price can cost less over six months than a $99 starting price that climbs to $299 at your maintenance dose.

Why the price climbs with dose, and who charges flat

Tirzepatide is titrated: you start at a low dose and step up every few weeks. Compounded tirzepatide is priced by the milligram, so a program that charges by dose may bill your maintenance month at two or three times the starting price. That is why 260 published prices start with "From." In most cases, that word means "at the lowest dose."

Programs price in one of three ways:

  1. Flat at every dose. One price from your first month to your last. These programs carry the higher starting numbers, because the price already includes the maintenance doses.
  2. Dose-tiered. The advertised price applies to the starting dose. Ask for the price at the dose you expect to reach, not the dose you start on.
  3. Term-tiered. The lowest rate requires prepaying 3, 6 or 12 months. The month-to-month rate is higher, and a prepaid plan is often non-refundable once the medication ships.

Some programs combine dose tiers and term tiers. Our teaser-rate trap guide covers the common patterns: first-month prices, separate membership bills, and "monthly" plans billed every 21 or 28 days.

What the monthly price includes

Two programs both listed at $199 can produce very different bills. Before you compare, check:

  • The clinician visit. Some prices include the medical review. Others charge a separate consult or membership fee every month or every year.
  • Shipping. Compounded tirzepatide ships cold. Some prices include shipping, and others add it at checkout.
  • Supplies. Syringes and alcohol swabs are sometimes included and sometimes extra.
  • How often you are billed. Some "monthly" plans bill every 28 days, which adds up to 13 bills a year instead of 12.
  • What happens if you stop. Prepaid plans often refund nothing once the medication ships.

Our table above groups advertised figures without normalizing their supply lengths or including every separate fee. Where a program bills a separate required fee, we note it in that program's review.

Compounded tirzepatide vs Zepbound per month

Eli Lilly sells Zepbound (brand-name tirzepatide) directly to self-pay patients. The single-patient-use KwikPen costs $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. A purchase offer cuts 7.5 mg and higher to $449, but only if you refill within 45 days of your previous fill1. Lilly also lists Zepbound single-dose vials from $299 a month1.

OptionPublished price and supply
Zepbound KwikPen, regular price (10 to 15 mg)$699 per 28-day fill
Zepbound KwikPen with the 45-day purchase offer$449 per 28-day fill
Compounded tirzepatide, median advertised figureabout $240; mixed offer units
Compounded tirzepatide, lowest unqualified monthly listing$129/mo

The advertised median cannot establish $200 in monthly savings: it mixes different doses, commitments and supply lengths. Compare the actual recurring bill at your prescribed dose. The products also differ:

  • Zepbound is FDA-approved. "Compounded drugs are not FDA-approved," and the FDA "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed"2.
  • The FDA says compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug," and it reports more than 730 adverse event reports tied to compounded tirzepatide as of May 31, 20263.

Our Zepbound cost guide covers the full brand price ladder and the 45-day rule. For a side-by-side comparison of compounded and brand-name prices, see compounded vs brand-name GLP-1 cost.

Why the rules affect what you pay

Compounded tirzepatide is sold during an FDA crackdown, and the rules can change which programs stay open and at what price.

The shortage is over. The FDA declared the tirzepatide injection shortage resolved. State-licensed 503A pharmacies had until February 18, 2025, and 503B outsourcing facilities had until March 19, 2025, to stop making versions that are "essentially copies" of the approved drug4. Since then, a compounded version is supposed to contain a change that a prescriber documents as making a significant difference for a specific patient4.

503A and 503B are held to different standards. State boards of pharmacy oversee 503A pharmacies, which are not subject to current good manufacturing practice (CGMP) requirements. 503B outsourcing facilities are overseen and inspected by the FDA and must follow CGMP2.

The FDA has proposed closing the 503B route. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound them from bulk drug substances5. The comment docket was open through June 29, 20265. No final decision has been announced. If one comes, programs supplied by 503B facilities could change pharmacies or prices quickly.

Additives may not protect a product. Many programs sell tirzepatide combined with niacinamide, vitamin B6 or glycine. On September 18, 2026, the FDA issued a warning letter to a compounding pharmacy in Houston, Texas. The letter cited tirzepatide/niacinamide products made "regularly and in inordinate amounts" and called the differences from the approved drug "pretextual"6. If a program charges more for an additive blend, you are not buying regulatory protection.

How to check a price before you pay

  1. Ask for the price at your maintenance dose, not the starting dose. If the program will not tell you in writing, treat the advertised price as an intro rate.
  2. Ask for the month-to-month price. Divide any prepay plan by its true number of months and check the refund terms.
  3. Add up every bill, including membership, consult and shipping fees.
  4. Check how often you are billed. Count the number of charges per year.
  5. Ask for the pharmacy's name. Then check whether it is a 503A or 503B facility and look up its license. Our guide on how to verify a compounding pharmacy walks through each step, and is cheap compounded GLP-1 safe? explains what a low price can and cannot tell you.

To see every program's price in one sorted list, go to the cheapest tirzepatide ranking. To compare programs on more than price, see tirzepatide programs ranked by value.

Frequently asked questions

How much does compounded tirzepatide cost per month?

Across the 355 tirzepatide programs we track, counted November 2026, the median advertised figure is about $240 and the lower quartile is around $179. These figures mix starting offers, prepaid equivalents and supply lengths; they are not comparable monthly bills. The cheapest flat month-to-month price we found is $129. Most advertised prices are starting-dose or prepay rates, so expect to pay more at a maintenance dose unless the program charges one flat price.

Is compounded tirzepatide cheaper than Zepbound?

On price, usually. Lilly's self-pay Zepbound KwikPen costs $449 a month at 7.5 mg and higher with its 45-day refill offer, and $699 at 10 to 15 mg without it. The median compounded advertised figure is about $240, but mixed doses, commitments and supply lengths prevent a direct monthly savings calculation. But compounded tirzepatide is not FDA-approved, and the FDA does not verify its safety, effectiveness or quality, so it is not the same product at a lower price.

Why does my compounded tirzepatide price go up?

Most programs price by dose, and tirzepatide doses rise every few weeks. 229 of the 355 prices we track start with "From," which usually means the starting dose. Some programs also offer their lowest rate only on 3-, 6- or 12-month prepaid plans. A flat-priced program charges the same at every dose.

Is compounded tirzepatide still legal in 2026?

Pharmacies may still compound tirzepatide in limited circumstances, but the FDA ended the shortage-era rules in 2025. Copies of the approved drug are no longer allowed unless a prescriber documents a significant difference for a specific patient. In April 2026 the FDA also proposed excluding tirzepatide from the 503B bulks list. That proposal is not final.

Is tirzepatide with niacinamide or B6 worth paying more for?

Not for regulatory reasons. In a September 2026 warning letter, the FDA called the differences between tirzepatide/niacinamide products and the approved drug "pretextual." Judge an additive blend by its price and the pharmacy behind it, not by the additive.

References

  1. Eli Lilly and Company (2026). Zepbound Coverage & Savings — self-pay prices and purchase offer terms. zepbound.lilly.com. https://zepbound.lilly.com/coverage-savings
  2. U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  3. U.S. Food and Drug Administration (2026). FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  4. U.S. Food and Drug Administration (2026). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.gov. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  5. U.S. Food and Drug Administration (2026). FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List. FDA.gov. https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list
  6. U.S. Food and Drug Administration (2026). Warning Letter: Empower Clinic Services, LLC dba Empower Pharmacy (MARCS-CMS 738238). FDA.gov. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.